Tatyana Beldock

Board Member at Dyve Biosciences

Tatyana Beldock has 20+ years of operating and financial experience in healthcare. She has worked with companies at all stages, from startup (as a founder & CEO, board member, venture capitalist, investor, and advisor) to working as a senior executive at Fortune 50 leaders including Johnson & Johnson and Pfizer in addition to her financial roots (wall street research, bay area venture capital). Her track record includes 32 transactions exceeding $24B in value across biotech, health tech, medical devices, and financials.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Dyve Biosciences

1 followers

Dyve is a clinical-stage biotech company with its lead asset, DYV700, currently completing a 20-center, 100-patient, Phase 2 clinical study for the treatment of acute gout.


Industries

Employees

11-50

Links